The Global Radiation Therapy Quality Assurance (QA) Phantoms Market is expected to reach a market size of USD 36.4 Million by 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Quality check and assurance before delivering radiation treatment to a cancer patient is critical in order to maintain the radiation dose as prescribed by the doctor. Some major drivers fueling growth of the global market include enhancement of patient and machine quality assurance in radiation oncology, rising demand for tissue equivalent phantoms, and increasing number of cancer patients globally.
Dosimetry phantoms in radiation therapy treatment plays a vital role in ensuring the accuracy of a planned dose. Quality assurance phantoms are primarily used for calibration and characterization of delivery devices. Apart from that, phantoms are used for verifying distributions of modeled (planned) dose. Emerging economies are currently capable of providing better radiation treatment due to rapid advancements in medical technology. Growing concerns regarding patient safety during radiation treatment has been resulting in deployment of more stringent measures and practices, which is supporting demand for phantoms in the healthcare sector.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/505
Based on the competitive landscape, the market report analyzes the key companies operating in the industry:
Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., Sun Nuclear Corporation, The Phantom Laboratory Inc., Gammex Inc., and Gold Standard Phantoms.
Further Key Findings in the Report:
- In November 2020, PTW Freiburg GmbH (PTW) signed a distribution agreement with QRM GmbH. PTW became the sole global distributor of QRM’s tissue-equivalent phantoms from to beginning of January 2021.
- The Cobalt-60 segment in the global radiation therapy quality assurance (QA) phantoms market is expected to register a CAGR of 4.5% during forecast period. Cobalt-60 is primarily used to maintain the appropriate level of radiation and destroy malignant cells in tumor and cancer treatment.
- The market in Europe accounted for second-largest revenue share of 25.0% in 2020. Key factors such as growing focus on medical technology and governmental support are supporting growth of the market in this region.
Request a discount on the report @ https://www.emergenresearch.com/request-discount/505
For the purpose of this report, Emergen Research has segmented the global radiation therapy quality assurance (QA) phantoms market based on technology, therapy, application, and region as follows:
Technology Outlook (Revenue: USD Million; 2020–2028)
- Linear Accelerators
- Cobalt-60
- High-Dose Radiation
- Low-Dose Radiation
Therapy Outlook (Revenue: USD Million; 2020–2028)
- Photon Beam Radiation Therapy
- Advanced 3-D Conformal Radiation Therapy
- Image Guided Radiation Therapy
- Intensity-modulated radiation therapy
- Volumetric Modulated Arc Therapy
- Intraoperative Radiotherapy
- Neutron Beam Therapy
- Brachytherapy
To know more about the report, click here @ https://www.emergenresearch.com/industry-report/radiation-therapy-quality-assurance-phantoms-market
Application Outlook (Revenue: USD Million; 2020–2028)
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Head and Neck Cancers
- Skin Cancer
- Other
Regional Outlook (Revenue: USD Million; 2020–2028)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Request customization on the report @ https://www.emergenresearch.com/request-for-customization/505
Key Benefits of Buying the Global Radiation Therapy Quality Assurance (QA) Phantoms Report:
- Comprehensive analysis of the changing competitive landscape
- Assists in decision making processes for the businesses along with detailed strategic planning methodologies
- The report offers an 8-year forecast and assessment of the Global Radiation Therapy Quality Assurance (QA) Phantoms Market
- Helps in understanding the key product segments and their estimated growth rate
- In-depth analysis of market drivers, restraints, trends, and opportunities
- Comprehensive regional analysis of the Global Radiation Therapy Quality Assurance (QA) Phantoms Market
- Extensive profiling of the key stakeholders of the business sphere
- Detailed analysis of the factors influencing the growth of the Global Radiation Therapy Quality Assurance (QA) Phantoms Market
Thank you for reading our report. To know more about the customization of the report, please get in touch with us, and our team will ensure the report is suited to your requirements.
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing Marketresearch and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkedIn | Twitter | Blogs
Latest Reports: Cloud Storage Market, HR Analytics Market
Trending Reports: Next Generation Battlefield Technology Market, Ground Defense System Market